nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aims & Scope/Editorial Board
|
|
|
2015 |
5 |
3 |
p. IFC- 1 p. |
artikel |
2 |
Author Index
|
|
|
2015 |
5 |
3 |
p. I-V nvt p. |
artikel |
3 |
General Information
|
|
|
2015 |
5 |
3 |
p. iv-v nvt p. |
artikel |
4 |
O12. Analysis of the molecular and cellular mechanisms regulated by magnesium sulphate in an in vitro model of the human placenta
|
Williamson, Rachel |
|
2015 |
5 |
3 |
p. 212- 1 p. |
artikel |
5 |
O83. Angiogenic factor imbalance contributes to the pathophysiology of preeclampsia among rural African women
|
Meeme, Allen |
|
2015 |
5 |
3 |
p. 231- 1 p. |
artikel |
6 |
O79. An intermediate sFlt-1/PlGF ratio without preeclampsia indicates preterm delivery
|
Ossada, Victoria |
|
2015 |
5 |
3 |
p. 229-230 2 p. |
artikel |
7 |
O82. Association between anti-angiogenic factor and signs of arterial aging in women with preeclampsia
|
Akhter, Tansim |
|
2015 |
5 |
3 |
p. 230-231 2 p. |
artikel |
8 |
O6. Association between fetal congenital heart defects and maternal risk of hypertensive disorders of pregnancy in concurrent and subsequent pregnancies
|
Boyd, Heather |
|
2015 |
5 |
3 |
p. 210- 1 p. |
artikel |
9 |
O75. B7 Costimulation and intracellular indoleamine-2,3-dioxygenase expression in peripheral blood of healthy pregnant and preeclamptic women
|
Toldi, Gergely |
|
2015 |
5 |
3 |
p. 228- 1 p. |
artikel |
10 |
O8. Cardiovascular risk factors, renin-angiotensin system gene polymorphisms, pregnancy course and outcomes in women with different forms of hypertension
|
Chulkov, Vasiliy |
|
2015 |
5 |
3 |
p. 210-211 2 p. |
artikel |
11 |
O119. Cardiovascular risk management after reproductive and pregnancy related disorders: A Dutch multidisciplinary evidence-based guideline
|
Heida, Karst |
|
2015 |
5 |
3 |
p. 235-236 2 p. |
artikel |
12 |
O13. Catechol-O-methyltransferase deficiency leads to hypersensitivity on the pressor response against angiotensin II
|
Ueki, Norikazu |
|
2015 |
5 |
3 |
p. 212-213 2 p. |
artikel |
13 |
O132. Comparison of groups with and without diabetes mellitus and preeclampsia in pregnancy: A retrospective case-control comparison
|
Uddin, M. Nasir |
|
2015 |
5 |
3 |
p. 241- 1 p. |
artikel |
14 |
O66. Comparison of immediate delivery versus expectant management in women with severe early onset preeclampsia before 26 weeks of gestation
|
Van Oostwaard, Miriam F. |
|
2015 |
5 |
3 |
p. 225-226 2 p. |
artikel |
15 |
O22. Correlation of sFlt-1/PlGF ratio with time to delivery or preterm birth in PROGNOSIS (prediction of short-term outcome in pregnant women with suspected preeclampsia study)
|
Zeisler, Harald |
|
2015 |
5 |
3 |
p. 216- 1 p. |
artikel |
16 |
O19. Decreased plasma hemopexin activity in preeclampsia is associated with decreased plasma AT-1 receptor levels and increased placental and monocyte AT-1 receptor expression
|
Spaan, Floor |
|
2015 |
5 |
3 |
p. 214-215 2 p. |
artikel |
17 |
O30. Diet and preeclampsia: A prospective multicentre unmatched case control study in Ethiopia
|
Endeshaw, Mulualem |
|
2015 |
5 |
3 |
p. 220- 1 p. |
artikel |
18 |
O28. Effect of folic acid supplementation in pregnancy on preeclampsia – Folic Acid Clinical Trial (FACT)
|
Wen, Shi Wu |
|
2015 |
5 |
3 |
p. 219-220 2 p. |
artikel |
19 |
O7. Epigenome of the circadian clock pathway of placental and newborn tissues in pre-eclampsia
|
Van den Berg, Caroline |
|
2015 |
5 |
3 |
p. 210- 1 p. |
artikel |
20 |
O125. Ethnicity: An independent risk factor for adverse perinatal outcome in women with chronic hypertension
|
Webster, Louise |
|
2015 |
5 |
3 |
p. 238-239 2 p. |
artikel |
21 |
O11. Evaluation of the endocannabinoid system in preeclampsia
|
Molvarec, Attila |
|
2015 |
5 |
3 |
p. 212- 1 p. |
artikel |
22 |
O25. Evaluation of the value of the first and third trimester maternal mean platelet volume (MPV) for prediction of pre-eclampsia
|
Kashanian, Maryam |
|
2015 |
5 |
3 |
p. 218-219 2 p. |
artikel |
23 |
O133. Fetal renal vascularisation in pregnancy induced hypertension complicated by gestational diabetes or intrauterine growth restriction
|
Surányi, Andrea |
|
2015 |
5 |
3 |
p. 241-242 2 p. |
artikel |
24 |
O115. First trimester maternal vascular function is associated with fetal growth
|
Iacobaeus, Charlotte |
|
2015 |
5 |
3 |
p. 234- 1 p. |
artikel |
25 |
O21. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with later pre-eclampsia
|
Keikkala, Elina |
|
2015 |
5 |
3 |
p. 215-216 2 p. |
artikel |
26 |
O77. Functional screening of toll-like receptors in seven trophoblast cell lines
|
Gierman, Lobke |
|
2015 |
5 |
3 |
p. 229- 1 p. |
artikel |
27 |
O4. Genome wide sequencing approaches to identify missing heritability of preeclampsia
|
Moses, Eric |
|
2015 |
5 |
3 |
p. 209-210 2 p. |
artikel |
28 |
O74. Granulocyte and monocyte phagocytosis index affected by plasma factors in normal and preeclamptic pregnancy
|
Lampé, Rudolf |
|
2015 |
5 |
3 |
p. 227-228 2 p. |
artikel |
29 |
O135. HELLP??? – A case
|
Weiss, Eva-Christine |
|
2015 |
5 |
3 |
p. 242- 1 p. |
artikel |
30 |
O123. Hypertensive disorders of pregnancy and subsequent risk of cancer – A population-based cohort study
|
Behrens, Ida |
|
2015 |
5 |
3 |
p. 237-238 2 p. |
artikel |
31 |
O10. Increased maternal and fetal HDL cholesterol efflux capacity and placental CYP27A1 expression in pre-eclampsia
|
Mistry, Hiten |
|
2015 |
5 |
3 |
p. 211-212 2 p. |
artikel |
32 |
O120. Increased Myeloperoxidase is a cardiovascular risk biomarker in women with previous preeclampsia
|
Matos, Andreia |
|
2015 |
5 |
3 |
p. 236- 1 p. |
artikel |
33 |
O112. Inotropy index and ratio of potential to kinetic energy: Two novel parameters derived from continuous-wave Doppler ultrasound
|
Bowe, Sophie |
|
2015 |
5 |
3 |
p. 233- 1 p. |
artikel |
34 |
O14. Is preeclampsia a variant of Liddles syndrome with enhanced activity of the epithelial sodium channel in the kidneys?
|
Nielsen, Lise Hald |
|
2015 |
5 |
3 |
p. 213- 1 p. |
artikel |
35 |
O65. Is there evidence to inform antihypertensive prescribing in pregnancy complicated by chronic hypertension: A systematic review
|
Webster, Louise |
|
2015 |
5 |
3 |
p. 225- 1 p. |
artikel |
36 |
O127. Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome
|
Ebina, Yasuhiko |
|
2015 |
5 |
3 |
p. 239-240 2 p. |
artikel |
37 |
O31. Magnesium homeostasis and gestational hypertension
|
Rylander, Ragnar |
|
2015 |
5 |
3 |
p. 221- 1 p. |
artikel |
38 |
O68. Management of eclampsia and stroke during pregnancy
|
Ono, Yasumasa |
|
2015 |
5 |
3 |
p. 226- 1 p. |
artikel |
39 |
O16. Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC–MS identification in human plasma
|
Lenaerts, Charline |
|
2015 |
5 |
3 |
p. 213-214 2 p. |
artikel |
40 |
O114. Maternal cardiovascular changes in pregnancies complicated by small for gestational age neonate with or without maternal hypertension
|
Bowe, Sophie |
|
2015 |
5 |
3 |
p. 234- 1 p. |
artikel |
41 |
O110. Maternal left ventricular dysfunction and remodeling in pregnancy complicated with gestational hypertension
|
Szenczi, Orsolya |
|
2015 |
5 |
3 |
p. 232- 1 p. |
artikel |
42 |
O121. Maternal metabolic outcomes in women with a history of hypertensive pregnancy disorders
|
Benschop, Laura |
|
2015 |
5 |
3 |
p. 236- 1 p. |
artikel |
43 |
O113. Measurements of arterial stiffness and uterine artery Doppler for the prediction of preeclampsia in women presenting with gestational hypertension
|
Khalil, Asma |
|
2015 |
5 |
3 |
p. 233-234 2 p. |
artikel |
44 |
O72. Monocyte–macrophage system in pregnancy complications from the prospective of extracellular vesicles
|
Pállinger, Éva |
|
2015 |
5 |
3 |
p. 227- 1 p. |
artikel |
45 |
O20. NT-pro-BNP levels as a marker of high clinical risk in pregnancy
|
Cabo Fustaret, Marcela Cleila |
|
2015 |
5 |
3 |
p. 215- 1 p. |
artikel |
46 |
O18. Oxidative stress in preeclampsia
|
Héjja, Hajnalka |
|
2015 |
5 |
3 |
p. 214- 1 p. |
artikel |
47 |
O128. Placental vascularization indices and uterine artery peak systolic velocity in pregnancy hypertension
|
Altorjay, Ábel Tamás |
|
2015 |
5 |
3 |
p. 240- 1 p. |
artikel |
48 |
O134. Polycystic ovary syndrome as a risk factor of pregnancy induced hypertension – Review of the literature
|
Várbíró, Szabolcs |
|
2015 |
5 |
3 |
p. 242- 1 p. |
artikel |
49 |
O126. Postnatal neurological development follow-up of newborns from pregnancies with hypertension associated intrauterine growth restriction (IUGR)
|
Joó, József Gábor |
|
2015 |
5 |
3 |
p. 239- 1 p. |
artikel |
50 |
O131. Pravastatin protects against glucose-induced anti-proliferative, anti-invasive and anti-angiogenic milieu in cytotrophoblasts
|
Uddin, M. Nasir |
|
2015 |
5 |
3 |
p. 241- 1 p. |
artikel |
51 |
O27. Predicting preeclampsia in a second pregnancy
|
Campbell, Doris |
|
2015 |
5 |
3 |
p. 219- 1 p. |
artikel |
52 |
O24. Prediction of pre-eclampsia in obese nulliparous women
|
Vieira, Matias |
|
2015 |
5 |
3 |
p. 218- 1 p. |
artikel |
53 |
O32. Pre-eclampsia and thrombophilia: Prevention issues
|
Zhuravleva, Ekaterina |
|
2015 |
5 |
3 |
p. 221- 1 p. |
artikel |
54 |
O124. Preeclampsia: Two different clinical phenotypes – Two different pregnancy outcomes
|
Khodzhaeva, Zulfiya |
|
2015 |
5 |
3 |
p. 238- 1 p. |
artikel |
55 |
O63. Removal of soluble Fms-like tyrosine kinase (sFlt-1) by plasma-specific apheresis: Pilot study in women with very preterm preeclampsia
|
Schaarschmidt, Wiebke |
|
2015 |
5 |
3 |
p. 224-225 2 p. |
artikel |
56 |
O117. Role of some biomarkers in long term cardiovascular prognosis of pregnancy hypertensive disease
|
Bicho, Manuel |
|
2015 |
5 |
3 |
p. 234-235 2 p. |
artikel |
57 |
O23. STEPS (Study of Early Preeclampsia in Spain): sFlt-1/PlGF for the prediction of early-onset preeclampsia in singleton pregnancies
|
Perales, Alfredo |
|
2015 |
5 |
3 |
p. 216-218 3 p. |
artikel |
58 |
O118. Subsequent preeclampsia is associated with worse subclinical left ventricular dysfunction
|
Chow, York Yann |
|
2015 |
5 |
3 |
p. 235- 1 p. |
artikel |
59 |
O111. The association between maternal haemodynamics and pre-eclampsia: Systematic review and meta-analysis
|
Selvi, Silvia |
|
2015 |
5 |
3 |
p. 233- 1 p. |
artikel |
60 |
O67. The cranial imaging in severe preeclampsia
|
Di, XiaoDan |
|
2015 |
5 |
3 |
p. 226- 1 p. |
artikel |
61 |
O9. The functional role of natriuretic peptides in preeclampsia
|
Szabó, Gábor |
|
2015 |
5 |
3 |
p. 211- 1 p. |
artikel |
62 |
O29. The impact of low dose aspirin after positive first trimester screening for pre-eclampsia
|
Lakovschek, Ioana-Claudia |
|
2015 |
5 |
3 |
p. 220- 1 p. |
artikel |
63 |
O81. The impact of uterine curettage post partum on maternal sFlt-1 concentration
|
Ossada, Victoria |
|
2015 |
5 |
3 |
p. 230- 1 p. |
artikel |
64 |
O78. The inflammatory role of HMGB1 in preeclampsia
|
Tangerås, Line |
|
2015 |
5 |
3 |
p. 229- 1 p. |
artikel |
65 |
O76. The role of costimulatory molecules in the pathogenesis of pre-eclampsia
|
Darmochwal-Kolarz, Dorota |
|
2015 |
5 |
3 |
p. 228- 1 p. |
artikel |
66 |
O122. The role of framing in modifying behavior to reduce cardiovascular risk after preeclampsia, a vignette study
|
Bokslag, Anouk |
|
2015 |
5 |
3 |
p. 236-237 2 p. |
artikel |
67 |
O73. The role of Th17/Treg imbalance in normal pregnancy and pre-eclampsia
|
Darmochwal-Kolarz, Dorota |
|
2015 |
5 |
3 |
p. 227- 1 p. |
artikel |
68 |
O80. The SFLT-1/PlGF ratio associates with prolongation of pregnancy
|
Saleh, Langeza |
|
2015 |
5 |
3 |
p. 230- 1 p. |
artikel |
69 |
O61. The treatment of antenatal hypertension with labetalol: A prediction model for successful response
|
Stott, Daniel |
|
2015 |
5 |
3 |
p. 223-224 2 p. |
artikel |
70 |
O60. Treatment of hypertension in pregnancy
|
Farsang, Csaba |
|
2015 |
5 |
3 |
p. 223- 1 p. |
artikel |
71 |
O130. Urinary congophilia in women with preeclampsia and chronic kidney disease
|
McCarthy, Fergus |
|
2015 |
5 |
3 |
p. 240-241 2 p. |
artikel |
72 |
O62. Use of diuretics in the management of late-onset preeclampsia
|
Tamás, Péter |
|
2015 |
5 |
3 |
p. 224- 1 p. |
artikel |
73 |
O69. Visual evoked potential as neurophysiological evaluation of patients with severe PE and visual disturbances
|
Brussé, Ingrid |
|
2015 |
5 |
3 |
p. 226-227 2 p. |
artikel |
74 |
P87. Alteration of Delta-like ligand 1 and Notch 1 receptor in various placental disorders with special reference to early-onset preeclampsia
|
Shimanuki, Yota |
|
2015 |
5 |
3 |
p. 251- 1 p. |
artikel |
75 |
P37. Alterations in maternal and fetal plasma soluble endothelial leukocyte adhesion molecule-1 (sE-selectin) concentrations in women with pre-eclampsia
|
Kurlak, Lesia |
|
2015 |
5 |
3 |
p. 244- 1 p. |
artikel |
76 |
P89. Biochemical parameters of the first trimester in preeclampsia
|
Bogavac, Mirjana |
|
2015 |
5 |
3 |
p. 252- 1 p. |
artikel |
77 |
P53. Body mass index before pregnancy and hypertensive disorders in following pregnancy
|
Jakovljevic, Ana |
|
2015 |
5 |
3 |
p. 250-251 2 p. |
artikel |
78 |
P101. Cardiac function and ventriculo-arterial interaction 11years after preeclampsia complicated pregnancy
|
Al-Nashi, Maha |
|
2015 |
5 |
3 |
p. 256-257 2 p. |
artikel |
79 |
P43. Characterization of monocyte phenotype and polarization in preeclampsia and intrauterine fetal growth restriction
|
Alahakoon, Thushari |
|
2015 |
5 |
3 |
p. 246- 1 p. |
artikel |
80 |
P97. Chronic kidney disease and pregnancy – A case report
|
Mariana Miranda, Sara Nascimento |
|
2015 |
5 |
3 |
p. 254-255 2 p. |
artikel |
81 |
P39. Connection between placenta specific miRNA clusters and preeclampsia: a hypothetical miRNA–mRNA interaction network
|
Biró, Orsolya |
|
2015 |
5 |
3 |
p. 244-245 2 p. |
artikel |
82 |
P33. Decreasing of placental progesterone induced blocking factor expression and spiral artery remodeling disturbance in mice preeclampsia model
|
Wardhana, Manggala Pasca |
|
2015 |
5 |
3 |
p. 242-243 2 p. |
artikel |
83 |
P100. Differences in depression scores between women with a history of term hypertensive pregnancy disorders and women with a history of uncomplicated pregnancies
|
Hermes, Wietske |
|
2015 |
5 |
3 |
p. 256- 1 p. |
artikel |
84 |
P46. Dysregulated level of novel circulating autoantibodies in preeclampsia
|
Moe, Kjartan |
|
2015 |
5 |
3 |
p. 247-248 2 p. |
artikel |
85 |
P93. Early-onset eclampsia with intrauterine fetal death after placental abruption at 22 weeks gestation: A case report and literature review
|
Shigemitsu, Aiko |
|
2015 |
5 |
3 |
p. 253-254 2 p. |
artikel |
86 |
P90. Effect of angiotensin II receptor subtype2 stimulant on the pathogenesis of preeclampsia
|
Matsubara, Keiichi |
|
2015 |
5 |
3 |
p. 252- 1 p. |
artikel |
87 |
P47. First trimester urine and serum metabolomics to predict preeclampsia and gestational hypertension
|
Austdal, Marie |
|
2015 |
5 |
3 |
p. 248- 1 p. |
artikel |
88 |
P36. Identifying a novel link between preeclampsia and chronic hypertension in the MTHFR-gene using the population based Norwegian HUNT Study
|
Thomsen, Liv Cecilie |
|
2015 |
5 |
3 |
p. 243-244 2 p. |
artikel |
89 |
PL109. Corticosteroids in the management of severe preeclampsia: What evidence?
|
Vidaeff, Alex |
|
2015 |
5 |
3 |
p. 232- 1 p. |
artikel |
90 |
PL108. Inflammatory mechanisms in preeclampsia
|
Molvarec, Attila |
|
2015 |
5 |
3 |
p. 232- 1 p. |
artikel |
91 |
PL56. Long-term consequences of preeclampsia
|
Staff, Annetine |
|
2015 |
5 |
3 |
p. 222- 1 p. |
artikel |
92 |
PL59. The impact of classification of hypertensive disorders of pregnancy based on the ACOG 2013 and ISSHP 2014 criteria
|
Rigó Jr., János |
|
2015 |
5 |
3 |
p. 222-223 2 p. |
artikel |
93 |
P98. Maternal lipid- and steroid hormone concentrations during the course of pregnancy and in pregnancy pathologies
|
Pecks, Ulrich |
|
2015 |
5 |
3 |
p. 255- 1 p. |
artikel |
94 |
P50. Microalbuminuria is a predictor of adverse pregnancy outcomes including preeclampsia
|
Jayaballa, Mathini |
|
2015 |
5 |
3 |
p. 249- 1 p. |
artikel |
95 |
P40. MIR-21 and mir-221 overexpression in placental tissue of preeclamptic patients
|
Svecova, Iveta |
|
2015 |
5 |
3 |
p. 245- 1 p. |
artikel |
96 |
P35. Novel interaction of placental caveolin-1 expression with markers of oxidative stress and the renin-angiotensin system (RAS) in pre-eclampsia
|
Mistry, Hiten |
|
2015 |
5 |
3 |
p. 243- 1 p. |
artikel |
97 |
P95. Perinatal outcome of pregnant with severe preeclampsia and gestational diabetes mellitus in Rondônia – Brazil: Case report
|
Gimenez, Gizeli |
|
2015 |
5 |
3 |
p. 254- 1 p. |
artikel |
98 |
P102. Placental weight in the first pregnancy and risk for preeclampsia in second pregnancy: A population cohort study of 186 859 women
|
Larsen, Sandra |
|
2015 |
5 |
3 |
p. 257- 1 p. |
artikel |
99 |
P48. Possible laboratory markers and anthropometric women with preeclampsia – Preliminary results
|
Rosa, Natine Fuzihara |
|
2015 |
5 |
3 |
p. 248-249 2 p. |
artikel |
100 |
P91. Possible therapeutics for preeclampsia: drug repositioning by In Vitro screening via induction of placental growth factor
|
Mimura, Kazuya |
|
2015 |
5 |
3 |
p. 252-253 2 p. |
artikel |
101 |
P94. Preeclampsia in pregnancies with and without diabetes; the associations with placental weight. A population study of 655,842 pregnancies
|
Dypvik, Johanne |
|
2015 |
5 |
3 |
p. 254- 1 p. |
artikel |
102 |
P88. Pre-eclampsia risk stratification for low risk 1st pregnancies: First results of a new LC-MS based multiplex metabolite assay
|
Bond, Liz |
|
2015 |
5 |
3 |
p. 251-252 2 p. |
artikel |
103 |
P52. Prevalence of preeclampsia in patients of pre-gestational diabetic pregnancy in Bangladesh
|
Jahan, Mobashera |
|
2015 |
5 |
3 |
p. 250- 1 p. |
artikel |
104 |
P103. Relationship between severe preeclampsia onset with IUGR incidence at Dr. Soetomo General Hospital in 2013
|
Wicaksono, Budi |
|
2015 |
5 |
3 |
p. 257- 1 p. |
artikel |
105 |
P34. Role of high-mobility group A1 protein in trophoblast invasion
|
Uchikura, Yuka |
|
2015 |
5 |
3 |
p. 243- 1 p. |
artikel |
106 |
P51. Screening for preeclampsia in the first trimester: A reduced fat mass increases the risk in normo BMI patients
|
Tiralongo, Grazia Maria |
|
2015 |
5 |
3 |
p. 249-250 2 p. |
artikel |
107 |
P104. Stromal derived factor-1 α is a key to improving neonatal brain injuries
|
Mori, Miki |
|
2015 |
5 |
3 |
p. 258- 1 p. |
artikel |
108 |
P38. Strong inhibitory effect of preeclampsia serum on angiogenesis using in vitro angiogenesis test
|
Uotila, Uotila |
|
2015 |
5 |
3 |
p. 244- 1 p. |
artikel |
109 |
P44. Syncytiotrophoblast extracellular membrane vesicles from preeclamptic placentae show reduced abilities to guide monocyte maturation and activation as well as reduced activation of cytotoxicity of regulatory T-cells and NK-cells
|
Göhner, Claudia |
|
2015 |
5 |
3 |
p. 246-247 2 p. |
artikel |
110 |
P45. Target cells of pregnancy-associated extracellular vesicles
|
Kovács, Árpád Ferenc |
|
2015 |
5 |
3 |
p. 247- 1 p. |
artikel |
111 |
P41. The role of IL-10 polymorphism in pathology of hypertensive disorders in pregnancy
|
Zubor, Pavol |
|
2015 |
5 |
3 |
p. 245-246 2 p. |
artikel |
112 |
P42. TNF-ALPHA gene polymorphism in pathology of preeclampsia
|
Zubor, Pavol |
|
2015 |
5 |
3 |
p. 246- 1 p. |
artikel |
113 |
P99. Use of high dose cortisosteroids in HELLP syndrome
|
Lakovschek, Ioana-Claudia |
|
2015 |
5 |
3 |
p. 255-256 2 p. |
artikel |
114 |
P92. When there is a lack of magnesium during pregnancy
|
Vachulova, Anna |
|
2015 |
5 |
3 |
p. 253- 1 p. |
artikel |
115 |
STA106. Maternal cardiac function before and during preeclampsia: We must study the heart in pregnancy
|
Valensise, Herbert |
|
2015 |
5 |
3 |
p. 231-232 2 p. |
artikel |
116 |
STA55. Pathophysiology of preeclampsia from the view point of immunology
|
Saito, Shigeru |
|
2015 |
5 |
3 |
p. 222- 1 p. |
artikel |
117 |
STA54. Preeclampsia – Myths are still stronger than scientific data
|
Huppertz, Berthold |
|
2015 |
5 |
3 |
p. 221- 1 p. |
artikel |
118 |
STA1. What’s new in pre-eclampsia?
|
Brown, Mark |
|
2015 |
5 |
3 |
p. 209- 1 p. |
artikel |
119 |
Welcome message from the ISSHP 2015 Congress Chairman
|
Rigó Jr., János |
|
2015 |
5 |
3 |
p. iii- 1 p. |
artikel |